| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Interest income: |
| Interest income on loans | 169.2 | 139.2 | 151.7 | 152.5 | 112.1 | 91.7 | 86.2 | 66.7 |
| Interest income on investments | 44.0 | 30.7 | 22.3 | 23.5 | 21.4 | 19.2 | 17.1 | 14.9 |
| | 218.9 | 170.4 | 174.4 | 176.5 | 133.7 | 111.0 | 103.4 | 81.6 |
| Interest on deposits | 13.5 | 5.0 | 13.7 | 23.8 | 13.6 | 7.1 | 5.2 | 4.0 |
| Total interest expense | 18.3 | 9.5 | 19.1 | 31.2 | 19.1 | 11.1 | 8.5 | 6.1 |
| Net interest income | 200.6 | 160.8 | 155.2 | 145.2 | 114.6 | 99.9 | 94.9 | 75.6 |
| Provision for loan losses | | | | | | 1.8 | 1.2 | |
| Net interest income after provision for loan losses | 200.6 | 160.8 | 155.2 | 145.2 | 114.6 | 98.2 | 93.7 | 75.6 |
| Deposit and loan fees | | | | | | | | 4.8 |
| Gain on sale of investments, net | | | | | | | | 0.7 |
| Other non-interest income | 59.1 | 59.5 | 54.5 | 45.5 | 37.1 | 31.9 | 32.0 | 21.9 |
| Total non-interest income | 59.1 | 59.5 | 54.5 | 45.5 | 37.1 | 31.9 | 32.0 | 27.4 |
| Non-interest expenses | 154.2 | 124.0 | 117.1 | 114.2 | 93.6 | 77.8 | 76.6 | 61.3 |
| Pre-tax income | 99.2 | 102.8 | 75.0 | 71.2 | 56.1 | 52.2 | 49.1 | 41.7 |
| Income taxes | 17.4 | 18.6 | 12.8 | 12.0 | 9.5 | 11.5 | 13.9 | 11.6 |
| Tax rate | 17.5% | 18.1% | 17.1% | 16.9% | 17.0% | 22.1% | 28.4% | 27.9% |
| Net income | 81.8 | 84.1 | 62.2 | 59.2 | 46.5 | 40.7 | 35.2 | 30.1 |
| Net margin | 30.3% | 36.7% | 28.5% | 29.7% | 29.1% | 31.3% | 28.0% | 29.2% |
| |
| Basic EPS | $2.78 | $3.17 | $2.34 | $2.29 | $1.99 | $1.77 | $1.57 | $1.51 |
| Diluted EPS | $2.78 | $3.17 | $2.34 | $2.29 | $1.99 | $1.77 | $1.57 | $1.51 |
| |
| Shares outstanding (basic) | 29.5 | 26.5 | 26.5 | 25.8 | 23.4 | 22.9 | 22.4 | 19.9 |
| Shares outstanding (diluted) | 29.5 | 26.5 | 26.5 | 25.8 | 23.4 | 22.9 | 22.4 | 19.9 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |